RSA® Conference Europe 2012 Opens Today in London
9.10.2012 09:00:18 CEST | Business Wire | Press release
Keynote Lineup Includes Wikipedia Founder Jimmy Wales, Author and Journalist Misha Glenny and BT Chief Security Technology Advisor Bruce Schneier
The top information security professionals and business leaders across Europe gathered today for the opening of the 13th annual RSA® Conference Europe being held at the Hilton London Metropole Hotel, U.K. Taking place 9th-11th October, RSA Conference Europe 2012 will bring together the information security community’s best minds to address new and innovative strategies aimed at enabling businesses while protecting against emerging threats.
Through interactions with peers working the front lines and top industry experts, RSA Conference Europe 2012 is the event for security professionals learn best practices for keeping their organizations safe and sharpening their skill sets by attending sessions from a notable lineup of keynote speakers , including:
- Jimmy Donal Wales , Internet Entrepreneur and Founder of Wikipedia
- Art Coviello , Executive Vice President of EMC Corporation and Executive Chairman of RSA, The Security Division of EMC
- Joshua Corman , Director, Security Intelligence, Akamai Technologies
- Adrienne Hall , General Manager, Trustworthy Computing Microsoft Corporation
- Misha Glenny , Journalist and Author of DarkMarket: How Hackers Became the New Mafia
- Bruce Schneier , Chief Security Technology Officer, BT
- Francis deSouza , Group President, Enterprise Products and Services, Symantec
- Philippe Courtot , Chairman and Chief Executive Officer, Qualys Inc.
- Herbert “Hugh” Thompson, Ph.D , RSA Conference Programme Committee Chairman RSA Conference
“Each year, RSA Conference strives to help security professionals share, connect and engage to answer the most difficult questions facing our industry,” said XXX. “In 2012, businesses are coming to the realization that security has completely evolved beyond traditional borders. The convergence of personal devices, privacy and protection is forcing major changes in the modern enterprise. Our goal is to provide professionals with the top experts with proven, real-life advice that attendees can apply to their own work environments and RSA Conference Europe aligns perfectly with our mission.”
Some of the highlights at RSA Conference Europe 2012 include:
- Author’s Studio – On Tuesday, 9 October and Wednesday, 10 October visit the Crypto Commons to hear from renowned authors of information security literature – including both fact and fiction – during the all-new Author’s Studio sessions. During insightful 30-minute interviews, moderators will pose some initial questions and then it is your turn to ask what’s on your mind.
- The Science Lab : Live RAT Dissection – Scheduled for Tuesday, 9 October, Uri Fleyder, Cyber Lab Senior Researcher, RSA, The Security Division of EMC and Uri Rivner, Head of Cyber Strategy, Biocatch, will investigate why remote administration tools are spreading like wildfire in the cybercrime underground. The discussion aims to reveal recent Cyber Intelligence findings and dissect the new VNC Trojan add-on, showing an end-to-end online banking fraud operation using the most blood-chilling attack vector the financial industry has seen to date.
- UK Government Lunch Session – On Tuesday, 9 October, join the UK Cabinet Office's Government Digital Service for an informative session to learn how they are developing a pan-Government model for identity assurance through a series of 'alpha' projects. This session will describe the approach with a focus on one of its alpha projects.
- The Mobile Criminal: A Pocket Full of Maliciousness – Scheduled for Tuesday, 9 October, Gunter Ollmann, Vice President, Research, Damballa’s session will cover how criminals are becoming more and more adept at infecting mobile devices. As consumers’ concern over threats that target their mobile devices grows, the criminals tasked with engineering the tools for distributing and controlling their crimeware are becoming increasingly proficient. This session will reveal the latest insight into the mobile threat - focusing on the criminals behind the attacks.
- Cracked SSL? – On Tuesday, 9 October, this panel, led by Ben Wilson, SVP Industry Relations/Gen. Counsel, DigiCert, will discuss how to mitigate or prevent active Man-In-The-Middle attacks. We examine attacks that use combinations of social engineering, malware, DNS, and certificate mis-issuance or issuance process compromises involving CAs to compromise SSL sessions on unpatched, misconfigured, or poorly designed systems, tricking users into disclosing sensitive information.
- Town Hall Debate Sessions – Scheduled for Wednesday, 10 October, join peers in the RSA Conference community for informal Town Hall sessions in the Crypto Commons Theatre. Sessions include Dr. Marnix Dekker, Security Expert and Information Security Officer, ENISA discussing his latest Cloud Security research. This discussion will be followed by a fast-paced and interactive panel featuring RSA Conference Programme Committee Chairman Hugh Thompson leading a conversation with Wolfgang Kandek, CTO at Qualys, and Josh Corman, Director of Security Intelligence at Akamai, to dissect the industry’s most pressing topics.
- Cyber Jihad vs Cyberterrorism - Separating Hype from Reality – On Thursday, 11 October, Dancho Danchev will explore the basics of cyber jihad discussing in-depth the technical capabilities of cyber jihadist hacking teams and their associated hacking literature. The presentation will consider the conflict of interest when it comes to intelligence agencies' way of handling these communities, next to a case study on the Global Islamic Media Front.
RSA Conference Europe would like to extend its thanks its 2012 sponsors: Microsoft; RSA, The Security Division of EMC; Symantec Corporation; Symantec; Qualys; BreakingPoint; HOB; Splunk; Akamai; Bromium; Check Point Software Technologies LTD; Deloitte; Evidon; Informatica; Mykonos; Phishme.com; and, Cabinet Office Government Digital Service.
A complete RSA Conference Europe 2012 agenda can be found at:
http://www.rsaconference.com/events/2012/europe/agenda.htm .
About RSA Conference
RSA Conference helps drive the global information security agenda with annual events in the U.S., Europe, and Asia. Throughout its almost 21-year history, RSA Conference consistently attracts the best and brightest in the field, creating opportunities to learn about information security’s most important issues through face-to-face and online interactions with peers, luminaries and emerging and established companies. As information security professionals work to stay ahead of ever-changing security threats and trends, they turn to RSA Conference for a 360-degree view of the industry. RSA Conference seeks to arm participants with the knowledge they need to remain at the forefront of the information security business. More information on events, online programming and the most up-to-date news pertaining to the information security industry can be found at www.rsaconference.com .
No. No. No.
RSA and the RSA Conference logo are either registered trademarks or trademarks of EMC Corporation in the United States and/or other countries. All other products and/or services referenced are trademarks of their respective companies.
Contact:
RSA Conference
Andi Lustak
+44 20 81239946
andi.lustak@gmail.com
About Business Wire
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
From Network Automation to Agentic NetOps: NetBrain Sets the Standard for Deploying AI in Network Operations29.5.2026 15:00:00 CEST | Press release
Newest expansion of the NetBrain platform delivers Agent Skills, AI Path Doctor, MCP Server, and expanded cross-domain integrations, extending the agentic capabilities already running in production at hundreds of enterprises. NetBrain Technologies, Inc. today announced major new platform features that advance Agentic NetOps from an emerging category to operational reality. NetBrain's clients are already deploying agents that are diagnosing and remediating issues across complex multi-vendor enterprise networks. These new features further extend the platform with new agent tooling, cross-domain context, and open interfaces for the broader agentic enterprise. Early customer outcomes show the magnitude of the shift: A leading health insurer used NetBrain's Deep Diagnosis agent to diagnose and resolve a weeks old VPN connectivity issue in under five minutes. A large manufacturer resolved a critical device issue with a single prompt, isolating the root cause across the network path in under
Adtran resolves long-running patent litigation, reinforcing commitment to defend innovation29.5.2026 14:00:00 CEST | Press release
News summary: Non-practicing entity litigation continues to create costly, time-consuming pressure across the technology industry Adtran has reached a full settlement following counterclaims, with payment made to Adtran and all claims dismissed with prejudice Outcome reflects Adtran’s commitment to defend its innovations, customers and business against meritless patent assertions Adtran today announced it has resolved a patent litigation matter, resulting in a full settlement and dismissal of all claims with prejudice. The case, initiated in 2020 by a non-practicing entity asserting five patents, was transferred to the US District Court for the Northern District of Alabama in 2021 following a successful motion by Adtran. Adtran subsequently filed counterclaims, including bad-faith patent assertion under Alabama statutory law. The settlement includes payment to Adtran to resolve its counterclaims. Terms of the agreement remain confidential. “This outcome reflects a disciplined and consi
Meiji Seika Pharma Invests in GHIC’s Global Health Security Fund29.5.2026 13:00:00 CEST | Press release
Meiji Seika Pharma Co., Ltd. (Headquarters: Tokyo, Japan; President and Representative Director: Toshiaki Nagasato) today announced that it has committed to invest in the Global Health Security Fund (GHSF), which is sponsored by Global Health Investment Corporation (GHIC), a New York-based nonprofit organization. Through this investment, Meiji Seika Pharma will support the acceleration of innovations addressing critical global health challenges, including pandemic preparedness and antimicrobial resistance (AMR). GHIC is a mission‑driven nonprofit organization that deploys private investment strategies to generate both global health impact and financial returns. GHIC recently closed its second fund in GHSF. With more than a decade of experience investing in the field of infectious disease, GHIC has contributed to addressing major global health challenges. Its portfolio companies have successfully commercialized more than a dozen products, collectively reaching over 600 million people wo
IFF Enters Into Agreement to Sell Its Food Ingredients Business to CVC29.5.2026 12:50:00 CEST | Press release
Transaction advances portfolio transformation, sharpens focus on higher-growth, higher-margin businesses, strengthens balance sheet, and enhances value creation for shareholders IFF (NYSE: IFF), a global leader in flavors, fragrances, food ingredients, and health and biosciences, today announced that it has entered into an agreement to sell its Food Ingredients business to funds advised by CVC Capital Partners, a leading global private markets manager, in a transaction that values the business at approximately $4.3 billion, representing an enterprise value-to-EBITDA multiple of approximately 10x. As part of the transaction, IFF has chosen to retain an approximately 10% minority equity interest in the business, or approximately $200 million, permitting continued collaboration and cooperation between IFF and Food Ingredients and allowing IFF and its shareholders to participate in future value creation under its new ownership. The transaction marks a significant step in IFF’s portfolio tr
BeOne Medicines Establishes Standard for Long-Term Disease Control in CLL with BRUKINSA 78-Month Data at ASCO 202629.5.2026 12:00:00 CEST | Press release
Data represents the longest reported follow-up for a next-generation BTK inhibitor in CLL, showing sustained disease control and benefit that extends beyond first-line therapyBRUKINSA plus next-generation BCL2 inhibitor sonrotoclax (ZS) delivered deep, durable, and rapid uMRD responses, raising the bar for potential time-limited treatments in CLLData reinforce BeOne’s leadership in CLL and the strength of its foundational hematology franchise BeOne Medicines Ltd. (Nasdaq: ONC; HKEX: 06160; SSE: 688235), a global oncology company, is advancing the treatment paradigm in chronic lymphocytic leukemia (CLL) at the 2026 American Society of Clinical Oncology (ASCO) Annual Meeting. With extensive long-term follow-up, the SEQUOIA study of BRUKINSA® (zanubrutinib) reinforces its role as the foundational BTK inhibitor, showing sustained disease control over years of therapy. These findings are further supported by real-world evidence across three large analyses encompassing more than 250,000 pati
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
